相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients
Fabian Hammer et al.
KIDNEY INTERNATIONAL (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan et al.
KIDNEY INTERNATIONAL (2019)
Mineralocorticoid Receptor Blockade in End-Stage Renal Disease
Radmila Lyubarova et al.
CURRENT HYPERTENSION REPORTS (2017)
Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study
ChongTing Lin et al.
JOURNAL OF CLINICAL HYPERTENSION (2016)
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis
Kevin Quach et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis
RenJie Lu et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
The Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled Trial
Michael Walsh et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Path physiology to Treatment
Luca Di Lullo et al.
CARDIORENAL MEDICINE (2015)
The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?
Daniel Batlle et al.
EBIOMEDICINE (2015)
Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone for Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients
Somchai Yongsiri et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2015)
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease
David M. Charytan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Effects of Spironolactone on Dialysis Patients With Refractory Hypertension: A Randomized Controlled Study
Xiaoying Ni et al.
JOURNAL OF CLINICAL HYPERTENSION (2014)
Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
Yoshihiro Matsumoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients
Yasuhiko Ito et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
Antonio Vukusich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials
Justin A. Ezekowitz et al.
EUROPEAN HEART JOURNAL (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients
Sang-Woong Han et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure
B Pitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients
E Gross et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
分享论文
